These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31310505)

  • 41. Structure of human Fyn kinase domain complexed with staurosporine.
    Kinoshita T; Matsubara M; Ishiguro H; Okita K; Tada T
    Biochem Biophys Res Commun; 2006 Aug; 346(3):840-4. PubMed ID: 16782058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.
    Appel CK; Gallego-Pedersen S; Andersen L; Blancheflor Kristensen S; Ding M; Falk S; Sayilekshmy M; Gabel-Jensen C; Heegaard AM
    Sci Rep; 2017 Jul; 7(1):4792. PubMed ID: 28684771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.
    Najjar M; Suebsuwong C; Ray SS; Thapa RJ; Maki JL; Nogusa S; Shah S; Saleh D; Gough PJ; Bertin J; Yuan J; Balachandran S; Cuny GD; Degterev A
    Cell Rep; 2015 Mar; 10(11):1850-60. PubMed ID: 25801024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein kinase inhibition of clinically important staurosporine analogues.
    Gani OA; Engh RA
    Nat Prod Rep; 2010 Apr; 27(4):489-98. PubMed ID: 20336234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tethering small molecules to a phage display library: discovery of a selective bivalent inhibitor of protein kinase A.
    Meyer SC; Shomin CD; Gaj T; Ghosh I
    J Am Chem Soc; 2007 Nov; 129(45):13812-3. PubMed ID: 17944472
    [No Abstract]   [Full Text] [Related]  

  • 46. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
    Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
    Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Native Mass Spectrometry, Ion mobility, and Collision-Induced Unfolding Categorize Malaria Antigen/Antibody Binding.
    Huang Y; Salinas ND; Chen E; Tolia NH; Gross ML
    J Am Soc Mass Spectrom; 2017 Nov; 28(11):2515-2518. PubMed ID: 28875466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
    PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.
    Wurz RP; Sastri C; D'Amico DC; Herberich B; Jackson CLM; Pettus LH; Tasker AS; Wu B; Guerrero N; Lipford JR; Winston JT; Yang Y; Wang P; Nguyen Y; Andrews KL; Huang X; Lee MR; Mohr C; Zhang JD; Reid DL; Xu Y; Zhou Y; Wang HL
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5580-5590. PubMed ID: 27769621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parallel production and verification of protein products using a novel high-throughput screening method.
    Tegel H; Yderland L; Boström T; Eriksson C; Ukkonen K; Vasala A; Neubauer P; Ottosson J; Hober S
    Biotechnol J; 2011 Aug; 6(8):1018-25. PubMed ID: 21681961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors.
    Liu Y; Peng X; Guan X; Lu D; Xi Y; Jin S; Chen H; Zeng L; Ai J; Geng M; Hu Y
    Eur J Med Chem; 2017 Jan; 126():122-132. PubMed ID: 27750146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
    Sun M; Zheng Y; Wei H; Chen J; Ji M
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of a small-molecule inhibitor of death-associated protein kinase 1.
    Wilbek TS; Skovgaard T; Sorrell FJ; Knapp S; Berthelsen J; Strømgaard K
    Chembiochem; 2015 Jan; 16(1):59-63. PubMed ID: 25382253
    [No Abstract]   [Full Text] [Related]  

  • 55. Collision Induced Unfolding of Intact Antibodies: Rapid Characterization of Disulfide Bonding Patterns, Glycosylation, and Structures.
    Tian Y; Han L; Buckner AC; Ruotolo BT
    Anal Chem; 2015 Nov; 87(22):11509-15. PubMed ID: 26471104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
    Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
    Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16.
    Dixon-Clarke SE; Shehata SN; Krojer T; Sharpe TD; von Delft F; Sakamoto K; Bullock AN
    Biochem J; 2017 Feb; 474(5):699-713. PubMed ID: 28057719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the extra n-terminal methionine residue on the stability and folding of recombinant alpha-lactalbumin expressed in Escherichia coli.
    Chaudhuri TK; Horii K; Yoda T; Arai M; Nagata S; Terada TP; Uchiyama H; Ikura T; Tsumoto K; Kataoka H; Matsushima M; Kuwajima K; Kumagai I
    J Mol Biol; 1999 Jan; 285(3):1179-94. PubMed ID: 9887272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach.
    Allen JV; Bardelle C; Blades K; Buttar D; Chapman L; Colclough N; Dossetter AG; Garner AP; Girdwood A; Lambert C; Leach AG; Law B; Major J; Plant H; Slater AM
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5224-9. PubMed ID: 21835616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.